Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do state insurance mandates alter ICSI utilization?

25 Apr 2020

Abstract excerpt

BACKGROUND: Assisted reproductive technology (ART) insurance mandates resulted in improved access to infertility treatments like intracytoplasmic sperm injection (ICSI). Our objective was to examine whether ART insurance mandates demonstrate an increased association with ICSI use. METHODS: In this retrospective cohort study, clinic-specific data for 2000-2016 from the Centers for Disease Control (CDC) were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Prenatal Screening and Diagnostics
Share to Reproductive Health and Technologies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32334609
DOI: 10.1186/s12958-020-00589-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do state insurance mandates alter ICSI utilization?PMID 32334609Read ↗

Differences in ICSI Utilization Rates Among States With Insurance Mandates for ART CoverageSemantic proximity Read ↗

Impact of comprehensive state insurance mandates on in vitro fertilization utilization, embryo transfer practices, and outcomes in the United StatesSemantic proximity Read ↗

State-Mandated Insurance Coverage and Preimplantation Genetic Testing in the United StatesSemantic proximity Read ↗

In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factorsSemantic proximity Read ↗

Utilization of preimplantation genetic testing in the USASemantic proximity Read ↗

Insurance coverage and in vitro fertilization outcomes: a U.S. perspectiveSemantic proximity Read ↗

Embryo cryopreservation and utilization in the United States from 2004–2013Semantic proximity Read ↗

Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE and IFFS†‡Semantic proximity Read ↗

Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE†Semantic proximity Read ↗

Burden of care is the primary reason why insured women terminate in vitro fertilization treatmentSemantic proximity Read ↗

Assisted Reproduction in Spain, Outcome and Socioeconomic Determinants of AccessSemantic proximity Read ↗

Assisted reproductive technology use in the United States: a population assessmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.